Patents Assigned to Immunotech S.A.
  • Patent number: 7678583
    Abstract: A multifunctional reagent for erythrocytes containing an amount sufficient to produce the lysis of erythrocytes or the sphering of erythrocytes in such a way that they can be detected by a cytometer or an automatic counting device, of a carbamate or of an agent inducing the formation by the erythrocytes, from carbonate and from a nitrogenated heterocycle or ammonium ions, of a carbamate combined with the absorption of CO2 by the erythrocytes, process for lysing or sphering erythrocytes and preparation process for leucocytes.
    Type: Grant
    Filed: October 8, 2007
    Date of Patent: March 16, 2010
    Assignee: Immunotech, S.A.
    Inventors: Andre van Agthoven, Jean-Pierre Daziano, John Allen Maples
  • Publication number: 20090060937
    Abstract: Oligonucleotides containing the non-palindromic sequence motif: X1X2X3X4X5X6X7X8, wherein X1 is C, T, G or A (preferably T or C); wherein X2 is C, T, G or A; wherein X7 is C, T, G or A (preferably G); at least three, and preferably all, of X3, X4, X5, X6 and X8 are T; and with the proviso that, in the motif, a C does not precede a G (in other terms, the nucleic acid motif does not consist of a CpG oligonucleotide), that modulate the immune response of animals of the order Primate, including humans, are disclosed. This immune modulation is characterized by stimulation of proliferation, differentiation, cytokine production and antibody production on B-cells and cell differentiation on plasmacytoid dendritic cells.
    Type: Application
    Filed: April 28, 2008
    Publication date: March 5, 2009
    Applicant: IMMUNOTECH S.A.
    Inventor: Ricardo Agustin Lopez
  • Patent number: 7381807
    Abstract: Oligonucleotides containing the non-palindromic sequence motif: X1X2X3X4X5X6X7X8, wherein X1 is C,T,G or A (preferably T or C); wherein X2 is C,T,G or A; wherein X7 is C,T,G or A (preferably G); at least three, and preferably all, of X3, X4, X5, X6 and X8 are T; and with the proviso that, in the motif, a C does not precede a G (in other terms, the nucleic acid motif does not consist of a CpG oligonucleotide), that modulate the immune response of animals of the order Primate, including humans, are disclosed. This immune modulation is characterized by stimulation of proliferation, differentiation, cytokine production and antibody production on B-cells and cell differentiation on plasmacytoid dendritic cells.
    Type: Grant
    Filed: July 8, 2005
    Date of Patent: June 3, 2008
    Assignee: Immunotech S.A.
    Inventor: Ricardo Agustin Lopez
  • Patent number: 7300797
    Abstract: A multifunctional reagent for erythrocytes containing an amount sufficient to produce the lysis of erythrocytes or the sphering of erythrocytes in such a way that they can be detected by a cytometer or an automatic counting device, of a carbamate or of an agent inducing the formation by the erythrocytes, from carbonate and from a nitrogenated heterocycle or ammonium ions, of a carbamate combined with the absorption of CO2 by said erythrocytes, process for lysing or sphering erythrocytes and preparation process for leucocytes.
    Type: Grant
    Filed: September 14, 2001
    Date of Patent: November 27, 2007
    Assignee: Immunotech, S.A.
    Inventors: Andre van Agthoven, Jean-Pierre Daziano, John Allen Maples
  • Patent number: 7038029
    Abstract: Oligonucleotides containing the non-palindromic sequence motif: X1X2X3X4X5X6X7X8, wherein X1 is C,T,G or A (preferably T or C); wherein X2 is C,T,G or A; wherein X7 is C,T,G or A (preferably G); at least three, and preferably all, of X3, X4, X5, X6 and X8 are T; and with the proviso that, in the motif, a C does not precede a G (in other terms, the nucleic acid motif does not consist of a CpG oligonucleotide), that modulate the immune response of animals of the order Primate, including humans, are disclosed. This immune modulation is characterized by stimulation of proliferation, differentiation, cytokine production and antibody production on B-cells and cell differentiation on plasmacytoid dendritic cells.
    Type: Grant
    Filed: December 4, 2002
    Date of Patent: May 2, 2006
    Assignee: Immunotech S.A.
    Inventor: Ricardo Agustin Lopez
  • Publication number: 20050276789
    Abstract: Oligonucleotides containing the non-palindromic sequence motif: X1X2X3X4X5X6X7X8, wherein X1 is C,T,G or A (preferably T or C); wherein X2 is C,T,G or A; wherein X7 is C,T,G or A (preferably G); at least three, and preferably all, of X3, X4, X5, X6 and X8 are T; and with the proviso that, in the motif, a C does not precede a G (in other terms, the nucleic acid motif does not consist of a CpG oligonucleotide), that modulate the immune response of animals of the order Primate, including humans, are disclosed. This immune modulation is characterized by stimulation of proliferation, differentiation, cytokine production and antibody production on B-cells and cell differentiation on plasmacytoid dendritic cells.
    Type: Application
    Filed: July 8, 2005
    Publication date: December 15, 2005
    Applicant: IMMUNOTECH S.A.
    Inventor: Ricardo Lopez
  • Publication number: 20040006032
    Abstract: Oligonucleotides containing the non-palindromic sequence motif:
    Type: Application
    Filed: December 4, 2002
    Publication date: January 8, 2004
    Applicant: Immunotech S.A.
    Inventor: Ricardo Agustin Lopez